Literature DB >> 6829339

Status epilepticus: frequency, etiology, and neurological sequelae.

W A Hauser.   

Abstract

Status epilepticus is associated with high mortality and is a predictor of poor neurological outcome; yet the contribution of prolonged seizures to mortality and the causal sequence for neurological damage remain unclear. Many cases of status epilepticus are precipitated by illnesses that themselves are associated with increased mortality and morbidity. In studies of children, status epilepticus appears to be no better a predictor of an adverse outcome than is any seizure disorder starting at a similar age. Status epilepticus is a condition in which fast and definitive medical intervention is warranted. Random assignment to treatment groups is difficult. Evaluation of the effect of duration of seizures is also difficult, because those patients responding promptly to treatment may be quite a different population than those not responding. The study of cases of "nonconvulsive" status may provide information regarding the effect of these continuing ictal brain discharges, which can be evaluated without the confounding effects of concomitant metabolic (e.g., anoxic, pH, electrolyte) disturbances that accompany most cases of generalized status epilepticus. It is possible that appropriately designed prospective studies of status epilepticus and/or case-control studies will assist in evaluating the contribution of a prolonged seizure per se over and above that associated with preexisting or concurrent illness.

Entities:  

Mesh:

Year:  1983        PMID: 6829339

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  16 in total

Review 1.  Outcome of convulsive status epilepticus: a review.

Authors:  Claire L Novorol; Richard F M Chin; Rod C Scott
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

Review 2.  The clinical use of barbiturates in neurological disorders.

Authors:  M C Smith; B J Riskin
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures.

Authors:  J Bengzon; Z Kokaia; E Elmér; A Nanobashvili; M Kokaia; O Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Continuous midazolam infusion as treatment of status epilepticus.

Authors:  R L Koul; G Raj Aithala; A Chacko; R Joshi; M Seif Elbualy
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

5.  Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG.

Authors:  A M Husain; G J Horn; M P Jacobson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

6.  Prolonged activation of the N-methyl-D-aspartate receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture.

Authors:  R J DeLorenzo; S Pal; S Sombati
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

7.  Propofol in the management of refractory status epilepticus: a case report.

Authors:  A Borgeat; O H Wilder-Smith; P Jallon; P M Suter
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Selective loss of hilar neurons and impairment of initial learning in rats after repeated administration of electroconvulsive shock seizures.

Authors:  Nikolai V Lukoyanov; Maria J Sá; M Dulce Madeira; Manuel M Paula-Barbosa
Journal:  Exp Brain Res       Date:  2003-10-14       Impact factor: 1.972

9.  Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry.

Authors:  Laxmikant S Deshpande; Jeffrey K Lou; Ali Mian; Robert E Blair; Sompong Sombati; Elisa Attkisson; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

10.  Ictal catatonia as a manifestation of nonconvulsive status epilepticus.

Authors:  J Lim; P Yagnik; P Schraeder; S Wheeler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.